Electronic nicotine delivery systems: Executive summary of a policy position paper from the American College of Physicians

Ryan A. Crowley, Thomas Gerald Tape, Douglas M. De Long, Sue S. Bornstein, James F. Bush, Gregory A. Hood, Gregory C. Kane, Robert M. Lohr, Kenneth E. Olive, Shakaib U. Rehman, Micah Beachy, Tracey Henry, Ashley Minaei

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, or e-cigarettes, are growing in popularity, but their safety and efficacy as a smoking cessation aid are not well understood. Some argue that they have the potential to reduce tobacco-related morbidity and mortality and could be a useful tool for reducing tobacco-related harm. Others express concern that the health effects of ENDS use are unknown, that they may appeal to young people, and that they may encourage dual use of ENDS and traditional tobacco products. Although ENDS are a new and unregulated product, the U.S. Food and Drug Administration has proposed regulations that would deem ENDS to be subject to the Family Smoking Prevention and Tobacco Control Act, which regulates cigarettes and other tobacco products. In this position paper, the American College of Physicians offers policy recommendations on ENDS regulation and oversight, taxation, flavorings, promotion and marketing, indoor and public use, and research. This paper is not intended to offer clinical guidance or serve as an exhaustive literature review of existing ENDS-related evidence but to help direct the College, policymakers, and regulators on how to address these products.

Original languageEnglish (US)
Pages (from-to)583-584
Number of pages2
JournalAnnals of internal medicine
Volume162
Issue number8
DOIs
StatePublished - Apr 21 2015

Fingerprint

Nicotine
Physicians
Tobacco Products
Tobacco
Taxes
Smoking Cessation
United States Food and Drug Administration
Marketing
Smoking
Morbidity
Safety
Mortality
Health
Research

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Electronic nicotine delivery systems : Executive summary of a policy position paper from the American College of Physicians. / Crowley, Ryan A.; Tape, Thomas Gerald; De Long, Douglas M.; Bornstein, Sue S.; Bush, James F.; Hood, Gregory A.; Kane, Gregory C.; Lohr, Robert M.; Olive, Kenneth E.; Rehman, Shakaib U.; Beachy, Micah; Henry, Tracey; Minaei, Ashley.

In: Annals of internal medicine, Vol. 162, No. 8, 21.04.2015, p. 583-584.

Research output: Contribution to journalArticle

Crowley, RA, Tape, TG, De Long, DM, Bornstein, SS, Bush, JF, Hood, GA, Kane, GC, Lohr, RM, Olive, KE, Rehman, SU, Beachy, M, Henry, T & Minaei, A 2015, 'Electronic nicotine delivery systems: Executive summary of a policy position paper from the American College of Physicians', Annals of internal medicine, vol. 162, no. 8, pp. 583-584. https://doi.org/10.7326/M14-2481
Crowley, Ryan A. ; Tape, Thomas Gerald ; De Long, Douglas M. ; Bornstein, Sue S. ; Bush, James F. ; Hood, Gregory A. ; Kane, Gregory C. ; Lohr, Robert M. ; Olive, Kenneth E. ; Rehman, Shakaib U. ; Beachy, Micah ; Henry, Tracey ; Minaei, Ashley. / Electronic nicotine delivery systems : Executive summary of a policy position paper from the American College of Physicians. In: Annals of internal medicine. 2015 ; Vol. 162, No. 8. pp. 583-584.
@article{f7b60090d6a548478d8bb576e7ae049f,
title = "Electronic nicotine delivery systems: Executive summary of a policy position paper from the American College of Physicians",
abstract = "Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, or e-cigarettes, are growing in popularity, but their safety and efficacy as a smoking cessation aid are not well understood. Some argue that they have the potential to reduce tobacco-related morbidity and mortality and could be a useful tool for reducing tobacco-related harm. Others express concern that the health effects of ENDS use are unknown, that they may appeal to young people, and that they may encourage dual use of ENDS and traditional tobacco products. Although ENDS are a new and unregulated product, the U.S. Food and Drug Administration has proposed regulations that would deem ENDS to be subject to the Family Smoking Prevention and Tobacco Control Act, which regulates cigarettes and other tobacco products. In this position paper, the American College of Physicians offers policy recommendations on ENDS regulation and oversight, taxation, flavorings, promotion and marketing, indoor and public use, and research. This paper is not intended to offer clinical guidance or serve as an exhaustive literature review of existing ENDS-related evidence but to help direct the College, policymakers, and regulators on how to address these products.",
author = "Crowley, {Ryan A.} and Tape, {Thomas Gerald} and {De Long}, {Douglas M.} and Bornstein, {Sue S.} and Bush, {James F.} and Hood, {Gregory A.} and Kane, {Gregory C.} and Lohr, {Robert M.} and Olive, {Kenneth E.} and Rehman, {Shakaib U.} and Micah Beachy and Tracey Henry and Ashley Minaei",
year = "2015",
month = "4",
day = "21",
doi = "10.7326/M14-2481",
language = "English (US)",
volume = "162",
pages = "583--584",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "8",

}

TY - JOUR

T1 - Electronic nicotine delivery systems

T2 - Executive summary of a policy position paper from the American College of Physicians

AU - Crowley, Ryan A.

AU - Tape, Thomas Gerald

AU - De Long, Douglas M.

AU - Bornstein, Sue S.

AU - Bush, James F.

AU - Hood, Gregory A.

AU - Kane, Gregory C.

AU - Lohr, Robert M.

AU - Olive, Kenneth E.

AU - Rehman, Shakaib U.

AU - Beachy, Micah

AU - Henry, Tracey

AU - Minaei, Ashley

PY - 2015/4/21

Y1 - 2015/4/21

N2 - Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, or e-cigarettes, are growing in popularity, but their safety and efficacy as a smoking cessation aid are not well understood. Some argue that they have the potential to reduce tobacco-related morbidity and mortality and could be a useful tool for reducing tobacco-related harm. Others express concern that the health effects of ENDS use are unknown, that they may appeal to young people, and that they may encourage dual use of ENDS and traditional tobacco products. Although ENDS are a new and unregulated product, the U.S. Food and Drug Administration has proposed regulations that would deem ENDS to be subject to the Family Smoking Prevention and Tobacco Control Act, which regulates cigarettes and other tobacco products. In this position paper, the American College of Physicians offers policy recommendations on ENDS regulation and oversight, taxation, flavorings, promotion and marketing, indoor and public use, and research. This paper is not intended to offer clinical guidance or serve as an exhaustive literature review of existing ENDS-related evidence but to help direct the College, policymakers, and regulators on how to address these products.

AB - Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, or e-cigarettes, are growing in popularity, but their safety and efficacy as a smoking cessation aid are not well understood. Some argue that they have the potential to reduce tobacco-related morbidity and mortality and could be a useful tool for reducing tobacco-related harm. Others express concern that the health effects of ENDS use are unknown, that they may appeal to young people, and that they may encourage dual use of ENDS and traditional tobacco products. Although ENDS are a new and unregulated product, the U.S. Food and Drug Administration has proposed regulations that would deem ENDS to be subject to the Family Smoking Prevention and Tobacco Control Act, which regulates cigarettes and other tobacco products. In this position paper, the American College of Physicians offers policy recommendations on ENDS regulation and oversight, taxation, flavorings, promotion and marketing, indoor and public use, and research. This paper is not intended to offer clinical guidance or serve as an exhaustive literature review of existing ENDS-related evidence but to help direct the College, policymakers, and regulators on how to address these products.

UR - http://www.scopus.com/inward/record.url?scp=84928103019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928103019&partnerID=8YFLogxK

U2 - 10.7326/M14-2481

DO - 10.7326/M14-2481

M3 - Article

C2 - 25894027

AN - SCOPUS:84928103019

VL - 162

SP - 583

EP - 584

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 8

ER -